NAFLD is linked to several pathways, including the cancer pathway, the Hepatitis B pathway, the VEGFR1 signaling pathway, the IL-6 signaling pathway, the AP1 signaling pathway, and the HIF signaling pathway. This evidence concerns the gene FLT1 and metabolic dysfunction-associated steatotic liver disease.